Skip to main content
Veterinary Medicines

SEBACIL 50 % SOLUTION

Authorised
  • Phoxim

Product identification

Medicine name:
SEBACIL 50 % SOLUTION
Active substance:
  • Phoxim
Target species:
  • Cattle
  • Pig
  • Equid
  • Sheep
  • Goat
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Phoxim
    500.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Cutaneous solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Cattle
      • Meat and offal
        40
        day
      • Milk
        60
        day
    • Pig
      • Meat and offal
        10
        day
    • Equid
      • Milk
        60
        day
      • Meat and offal
        28
        day
    • Sheep
      • Meat and offal
        28
        day
      • Milk
        60
        day
    • Goat
      • Meat and offal
        28
        day
      • Milk
        60
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AF01
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/5882196 3/1985
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."